Fig. 3.
Relative HLA-G1 mRNA levels in PBMCs obtained from primary CL patients.
(A) Values are expressed as mean ± SD GAPDH-balanced ratios (as a result of triplicate runs) multiplied by 104. BC indicates buffy coat. (B) Relative HLA-G1 transcriptional levels in lesional skin and PBMCs of primary CL patients. Note that 4 patients with CTCL (TL6, TL9, TL11, TL12) exhibited an average 4 times higher HLA-G transcription in lesional skin than in PBMCs.
